» Articles » PMID: 37674498

The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease

Abstract

Sex (the physical and physiologic effects resulting from having specific combinations of sex chromosomes) and gender (sex-associated behaviours, expectations, identities, and roles) significantly affect the course of inflammatory bowel disease (IBD) and the experience of living with IBD. Sex-influenced physiologic states, like puberty, the menstrual cycle, pregnancy, and andropause/menopause may also impact and be impacted by IBD. While neither Crohn's disease nor ulcerative colitis is commonly considered sex-determined illnesses, the relative incidence of Crohn's disease and ulcerative colitis between males and females varies over the life cycle. In terms of gender, women tend to use healthcare resources at slightly higher rates than men and are more likely to have fragmented care. Women are more commonly prescribed opioid medications and are less likely than men to undergo colectomy. Women tend to report lower quality of life and have higher indirect costs due to higher rates of disability. Women are also more likely to take on caregiver roles for children with IBD. Women with IBD are more commonly burdened with adverse mental health concerns and having poor mental health has a more profound impact on women than men. Pregnant people with active IBD have higher rates of adverse outcomes in pregnancy, made worse in regions with poor access to IBD specialist care. The majority of individuals with IBD in Canada do not have access to a pregnancy-in-IBD specialist; access to this type of care has been shown to allay fears and increase knowledge among pregnant people with IBD.

Citing Articles

Sex differences in a Brazilian sample of patients with inflammatory bowel disease.

Pascholatto K, Santos L, Skare T, Ramos Junior O, Nisihara R Rev Assoc Med Bras (1992). 2024; 70(12):e20240963.

PMID: 39630730 PMC: 11639564. DOI: 10.1590/1806-9282.20240963.


Association of Childhood Abuse With Incident Inflammatory Bowel Disease.

Anyane-Yeboa A, Casey K, Roberts A, Lopes E, Burke K, Ananthakrishnan A Clin Transl Gastroenterol. 2024; 15(12):e00718.

PMID: 39450870 PMC: 11671083. DOI: 10.14309/ctg.0000000000000718.

References
1.
Rolston V, Boroujerdi L, Long M, McGovern D, Chen W, Martin C . The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study. Inflamm Bowel Dis. 2018; 24(2):387-393. PMC: 6196767. DOI: 10.1093/ibd/izx004. View

2.
Targownik L, Kaplan G, Witt J, Bernstein C, Singh H, Tennakoon A . Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis. Am J Gastroenterol. 2020; 115(1):128-137. DOI: 10.14309/ajg.0000000000000503. View

3.
Treharne G, Carroll R, Tan K, Veale J . Supportive interactions with primary care doctors are associated with better mental health among transgender people: results of a nationwide survey in Aotearoa/New Zealand. Fam Pract. 2022; 39(5):834-842. PMC: 9508874. DOI: 10.1093/fampra/cmac005. View

4.
Selinger C, Eaden J, Selby W, Brian Jones D, Katelaris P, Chapman G . Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2012; 7(6):e206-13. DOI: 10.1016/j.crohns.2012.09.010. View

5.
Blackwell J, Saxena S, Jayasooriya N, Bottle A, Petersen I, Hotopf M . Prevalence and duration of gastrointestinal symptoms before diagnosis of Inflammatory Bowel Disease and predictors of timely specialist review: a population-based study. J Crohns Colitis. 2020; . DOI: 10.1093/ecco-jcc/jjaa146. View